Skip to content
Screener

Insulet PODD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$32.61M+88.0%
Embecta Corp. logo
Embecta Corp.EMBC
$156M-18.1%
Medtronic logo
MedtronicMDT
Beta Bionics logo
Beta BionicsBBNX
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.79B-53.8%
Enterprise value$10.23B-53.4%
P/E26.1×-63.7×
P/S3.2×-5.8×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions, except share and per share data)June 30, 2026December 31, 2025
Property, plant and equipment, net858.6819.5
Other intangible assets, net115.1117.1
Goodwill51.651.6
Other assets290.8288.2
Total assets$3,165.1$3,190.4
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable$123.3$75.0

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's deferred tax assets and other non-current assets?
Insulet (PODD) reported deferred tax assets and other non-current assets of $290.8M in Q2 2026.
How has Insulet's deferred tax assets and other non-current assets changed year-over-year?
Insulet's deferred tax assets and other non-current assets decreased by 7.7% year-over-year, from $315.1M to $290.8M.
What is the long-term trend for Insulet's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Insulet's deferred tax assets and other non-current assets has grown at a 30.2% compound annual growth rate (CAGR), from $77M to $288.2M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Insulet's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude